SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-037485
Filing Date
2008-06-06
Accepted
2008-06-06 17:50:49
Documents
1
Period of Report
2008-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd210143.html 4  
1 FORM 4 rrd210143.xml 4 3817
  Complete submission text file 0001181431-08-037485.txt   6021
Mailing Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006
Business Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006 4253730171
SCOLR Pharma, Inc. (Issuer) CIK: 0000934936 (see all company filings)

IRS No.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1

Mailing Address 4333 BROOKLYN AVE NE SEATTLE WA 98185
Business Address C/O WASHINGTON MUTUAL BANK 1201 THIRD AVE 6TH FL SEATTLE WA 98101 2066743010
LEVY RICHARD M (Reporting) CIK: 0001077980 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31982 | Film No.: 08886666